Closing the “utility” topic of patents
I want to tell a story that, in fact, happened quite a long time (at the beginning of zero) and for some reason is very little known.
In the early 2000s, the standard anti-virus “cocktail” against HIV / AIDS (so-called HAART) cost an average of about 10K dollars a year in the world, and 4.5K in Brazil. This is because the 71st article of the Brazilian patent law allows the Brazilian government, under certain conditions, to ignore international patents and allow a local manufacturer to manufacture drugs bypassing the patent system.
The Brazilian government, under the threat of revocation of patents, regularly sought significant (40-65%) discounts, and in the event of the manufacturer’s refusal to meet, repeatedly resorted to a valid revocation of patents. As a result, over 5 years (1996-2000), Brazil was able to save more than $ 1 billion on patents of drugs for HIV / AIDS.
')
en.wikipedia.org/wiki/HIV/AIDS_in_Brazil#Drug_patents
Of course, such an indecent desire to save people’s life, rather than enrich poor pharmaceutical companies, met with serious resistance at the state level. The United States has repeatedly put pressure on Brazil through the WTO and put it on the notorious “List of 301” (this is exactly what Ukraine was brought to at ex.ua). So far to no avail. Kopirasty even agreed to this:
Like, ay-ay-ay, we will have nothing to develop new drugs for. Of course, there is nothing, because pharmaceutical companies spend only 13% of the budget on R & D (24% on marketing). And the people who are dying at this time - who counts them?
Well, and now there are willing to tell how extraordinarily useful patents are for the development of the economy?
In the early 2000s, the standard anti-virus “cocktail” against HIV / AIDS (so-called HAART) cost an average of about 10K dollars a year in the world, and 4.5K in Brazil. This is because the 71st article of the Brazilian patent law allows the Brazilian government, under certain conditions, to ignore international patents and allow a local manufacturer to manufacture drugs bypassing the patent system.
The Brazilian government, under the threat of revocation of patents, regularly sought significant (40-65%) discounts, and in the event of the manufacturer’s refusal to meet, repeatedly resorted to a valid revocation of patents. As a result, over 5 years (1996-2000), Brazil was able to save more than $ 1 billion on patents of drugs for HIV / AIDS.
')
en.wikipedia.org/wiki/HIV/AIDS_in_Brazil#Drug_patents
Of course, such an indecent desire to save people’s life, rather than enrich poor pharmaceutical companies, met with serious resistance at the state level. The United States has repeatedly put pressure on Brazil through the WTO and put it on the notorious “List of 301” (this is exactly what Ukraine was brought to at ex.ua). So far to no avail. Kopirasty even agreed to this:
If you are going to be uncontrollable.
Like, ay-ay-ay, we will have nothing to develop new drugs for. Of course, there is nothing, because pharmaceutical companies spend only 13% of the budget on R & D (24% on marketing). And the people who are dying at this time - who counts them?
Well, and now there are willing to tell how extraordinarily useful patents are for the development of the economy?
Source: https://habr.com/ru/post/138206/
All Articles